“Public Policy”

8 result(s)
Read the article: Why the Time Is Right for a New Pricing Model
Cost Management
A Guaranteed Net Cost model can adapt to evolving market trends and help payors stay ahead of manufacturer strategies such as authorized generics, and changing legislative... More
Briefing
Public Policy
Solutions such as POS rebates and $0 copay drug lists can lower costs for plans and consumers, while a one-size-fits-all approach could lead to unintended consequences, and higher... More
Briefing
Twisting mountain road in the Swiss alps
Public Policy
Proposed HHS rule would eliminate rebates PBMs negotiate for Part D plans and MCOs, and may eventually affect all plans. Manufacturers would retain 15% of rebates currently... More
Briefing
A glass of water and two pills
Cost Management
It's time to bust the myth about drug prices and rebates. Larry Merlo, President and CEO shared CVS Health’s perspective as an employer and PBM in an op-ed. More
Commentary
Sitting man holding two pills and a glass of water
Cost Management
CVS Health responded to the Administration's Blueprint on lowering drug costs and highlighted what the company does to control costs. We also recommended things the... More
Commentary
Female patient reading the information on a prescription pill bottle
Cost Management
With prescription drug prices very much in the news, the question often asked is: Who is responsible for high drug prices? Pharmaceutical manufacturers — and no one else — set... More
Commentary
Icon of female pharmacist
Public Policy
As health care costs continue to rise and demand for primary care providers outpaces supply, pharmacists are increasingly on the front lines of care utilizing their clinical... More
Commentary
Icon of documents with a checkmark symbol
Public Policy
A focus on prioritizing generic review and fostering competition could help in the battle against sky-rocketing prescription drug costs. More
Commentary